Zobrazeno 101 - 110
of 236
pro vyhledávání: '"Shuichi Miyawaki"'
Autor:
Torsten Haferlach, Satoru Miyano, Claudia Haferlach, Yasunobu Nagata, Tetsuichi Yoshizato, Keisuke Kataoka, Kenichi Chiba, Kenichi Yoshida, Yuichi Shiraishi, Wolfgang Kern, Martin Dugas, Yusuke Shiozawa, Hiroyuki Aburatani, Shigeru Chiba, Susanne Schnittger, Hiroko Tanaka, Shuichi Miyawaki, Tamara Alpermann, Niroshan Nadarajah, Vera Grossmann, Hideki Makishima, Phillip Koeffler, Hans-Ulrich Klein, Ayana Kon, Seishi Ogawa, Yosaku Watatani, Yusuke Okuno, Genta Nagae, Masashi Sanada, Tsuyoshi Nakamaki, Lee-Yung Shih
Publikováno v:
Blood. 126:2841-2841
Myelodysplastic syndromes (MDS) and related disorders are a heterogeneous group of chronic myeloid neoplasms with a high propensity to acute myeloid leukemia. A cardinal feature of MDS, as revealed by the recent genetic studies, is a high frequency o
Autor:
Kengo Takeuchi, Akira Hangaishi, Yoichi Imai, Shuichi Miyawaki, Ying Qiao, Lili Wang, Noriko Hosoya, Seishi Ogawa, Koichiro Yuji, Hisamaru Hirai
Publikováno v:
Blood. 99:3075-3077
Chk2 is a novel checkpoint kinase isolated as a human homologue of yeast Cds1/Rad53.[1][1] Recent analyses have revealed that it is among key molecules signaling DNA damage via the ATM protein kinase to p53.[1][1] [2][2] Of great interest is the repo
Autor:
Yasushi Miyazaki, Yukihiko Kimura, Kazunori Ohnishi, Shuichi Miyawaki, Kohmei Kubo, Yoko Adachi, Ryuzo Ueda, Shigeki Ohtake, Minoru Yoshida, Ryuzo Ohno, Takuhiro Yamaguchi, Hitoshi Kiyoi, Fumiharu Yagasaki, Tomoki Naoe, Atsushi Wakita, Satoru Takada, Akihiro Takeshita, Hirokazu Komatsu
Publikováno v:
International journal of hematology. 96(1)
We conducted a multicenter prospective randomized study to compare a fixed-scheduled induction therapy with a response-oriented individualized induction therapy for elderly patients with acute myeloid leukemia (AML). Newly diagnosed AML patients, age
Autor:
Noriko Usui, Yuichi Yahagi, Shigeki Ohtake, Chiaki Nakaseko, Akihiro Takeshita, Kazunori Ohnishi, Tomoki Naoe, Nobuaki Dobashi, Kazuyuki Shigeno, Hiroyuki Fujita, Chikako Ohwada, Hitoshi Kiyoi, Yukio Kobayashi, Shuichi Miyawaki, Toru Sakura, Yasushi Miyazaki
Publikováno v:
Cancer science. 102(7)
In order to investigate better molecular-target therapy for acute myeloid leukemia (AML), we conducted a phase I trial of a combination of gemtuzumab ozogamicin (GO) with conventional chemotherapy. Between January 2007 and December 2009, a total of 1
Autor:
Takahiro Yamauchi, Takashi Watanabe, Tomomitsu Hotta, Toru Sakura, Naokuni Uike, Kiyoshi Ando, Kensei Tobinai, Hiroya Asou, Toshiya Yokozawa, Kosuke Tsuboi, Rika Kihara, Shin Fujisawa, Shuichi Miyawaki
Publikováno v:
Leukemia research. 35(10)
Barasertib (AZD1152) is a highly potent and selective Aurora B kinase inhibitor. The safety, efficacy and pharmacokinetic (PK) profile of barasertib were investigated in Japanese patients with advanced acute myeloid leukemia. Barasertib (50-1200mg) w
Autor:
Jun Tsuchiya, Kenji Kashiwabara, Toru Sakura, Hiroko Shiozaki, Teruo Kitani, Kunihiko Yashiro, Hisami Hirabayashi, Shuichi Miyawaki, Hirokazu Murakami, Takashi Machii
Publikováno v:
Internal Medicine. 32:472-475
A 64-year-old male suffered from splenomegaly without lymphadenopathy. His WBC count on admission was 6.1×l09/l with 55% abnormal lymphocytes. No monoclonal gammopathy was detected. Abnormal cells shown in films usually had relatively abundant cytop
Autor:
Takuji Naruse, Hirokazu Murakami, Mitsuhiro Omine, Shuichi Miyawaki, Masamitsu Karasawa, Jun Tsuchiya, Hisami Hirabayashi, Etsuo Kawada
Publikováno v:
The KITAKANTO Medical Journal. 43:153-158
One hundred and fifty-five consecutive patients with acute myeloid leukemia (AML) seen between 1980 and 1989 were studied. Patients aged 60 years or more was retrospectively compared with those aged 59 years or less, regarding clinical features and t
Autor:
Shuichi, Miyawaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 51(10)
Autor:
Daisuke Koga, Tomoki Naoe, Kunio Kitamura, Toshiharu Tamaki, Takahiro Karasuno, Keiya Ozawa, Tamotsu Yamagami, Nahoko Hatsumi, Kinuko Mitani, Shuichi Miyawaki, Yoshihisa Kodera
Publikováno v:
Leukemialymphoma. 51(10)
We retrospectively analyzed the potential of Wilms' tumor gene 1 (WT1) mRNA levels in peripheral blood for predicting the prognosis of 50 patients with AML. After achieving complete remission (CR), 34 patients (69.4%) were determined to be positive a
Autor:
Hitoshi Kiyoi, Takahisa Yamane, Masatomo Takahashi, Yasushi Miyazaki, Tadashi Nagai, Hirokazu Okumura, Shigeki Ohtake, Sumihisa Honda, Chiaki Nakaseko, Tomoki Naoe, Yukihiko Kimura, Atsushi Fujieda, Hisashi Sakamaki, Shuichi Miyawaki, Katsuji Shinagawa, Kazunori Ohnishi, Koichi Miyamura, Ryuzo Ohno, Noriko Usui, Fumiharu Yagasaki, Hiroshi Handa, Hiroyuki Fujita, Masafumi Taniwaki, Norio Asou
Publikováno v:
Blood. 117(8)
We conducted a multi-institutional randomized study to determine whether high-dose daunorubicin would be as effective as standard-dose idarubicin in remission-induction therapy for newly diagnosed adult patients younger than 65 years of age with acut